Progyny (PGNY) Earnings Analysis
Progyny (PGNY) next reports earnings on 2026-08-06, consensus EPS 0.335 USD. Last quarter (2026-05-07) it beat with EPS 0.3 USD vs 0.256 USD est (+17.2%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E 38.70.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does PGNY next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | 0.335 USD |
| Revenue estimate | 0.35B |
PGNY earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | 0.3 USD | 0.256 USD | +17.2% | Beat |
| 2026-02-26 | 0.15 USD | 0.147 USD | +2% | Beat |
| 2025-11-06 | 0.45 USD | 0.39 USD | +15.4% | Beat |
| 2025-08-07 | 0.48 USD | 0.44 USD | +9.1% | Beat |
| 2025-05-08 | 0.48 USD | 0.45 USD | +6.7% | Beat |
| 2025-02-27 | 0.42 USD | 0.37 USD | +13.5% | Beat |
Beat rate: 6/6 (100%) over reported quarters with consensus data.
PGNY valuation and analyst view
| Trailing P/E | 38.70 |
|---|---|
| Trailing EPS | 0.83653 USD |
| Price / book | 5.77 |
| Dividend yield | 0.00% |
| Market cap | 2.46B |
| Analyst consensus | Buy (15 buy / 5 hold / 0 sell) |
| Avg price target | 33.2 USD |
Related research pages
Frequently asked questions
When is Progyny (PGNY)'s next earnings date?
Progyny is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 0.335 USD and revenue estimate of 0.35B.
Did PGNY beat earnings last quarter?
In its 2026-05-07 report, PGNY posted EPS of 0.3 USD versus a 0.256 USD estimate — a beat of 17.2%.
What is PGNY's earnings track record?
Over the last 6 reported quarters with consensus data, PGNY beat estimates 6 times (100%).
What is PGNY's current P/E ratio and EPS?
PGNY trades at a trailing P/E of 38.70 on trailing EPS of 0.8365319985630922 USD.
What do analysts rate PGNY?
Analyst consensus is "Buy" across 20 ratings (0 strong buy, 15 buy, 5 hold, 0 sell, 0 strong sell). Average 12-month price target: 33.2 USD.